Summary
The absorption of piretanide was investigated after placing the drug in the stomach, duodenum and ascending colon under visual control.
The relative amounts absorbed and the rates of absorption were estimated from the area under the curve and the total mean time, respectively.
Similar amounts of piretanide were absorbed and at almost the same rate after placement in the stomach and duodenum; the area under the curve for the stomach was 250 ng h/ml and for the duodenum 243 ng h/ml, the mean absorption times being 1.97 h and 1.51 h respectively. A marked difference was observed in the rate of from the ascending colon; the area amounted to 66 ng h/ml and the mean time to 3.99 h. Although area values for the colon were significantly different from those observed with the stomach and duodenum, it must be emphasised that the amount absorbed depends on the time the drug is in contact with the absorbing surface. There is discussion of whether the differences in absorption between the duodenum and colon can be explained by the physico-chemical properties of the drug alone, or whether the results reflect a saturable transport mechanism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ochs H, Bodem G, Schäfer PK, Kodrat G, Dengler HJ (1975) Absorption of digoxin from the distal part of the intestine in man. Eur J Clin Pharmacol 9: 95–97
Andersson KE, Nyberg L, Dencker H, Göthlin J (1975) Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization. Eur J Clin Pharmacol 9: 39–47
Meyer BH, Müller FO, Grigoleit H-G, Heptner W (1982) Endoscopic placement in volunteers to investigate site of absorption of piretanide: Preliminary report. IRCS Med Sci 10: 14
Gundert-Remy U, Hildebrandt R, Stiehl A, Weber E, Zurcher G, Da Prada M (1983) Intestinal absorption of levodopa in man. Eur J Clin Pharmacol 25: 69–72
Lunell E, Andersson K-E, Borgå O, Fagerström P-O, Johannesson N, Kjellin G, Persson CGA, Sjölund K (1984) Absorption of enprofylline from the gastrointestinal tract in healthy subjects. Eur J Clin Pharmacol 27: 329–333
Schuster O, Hartel M, Hagemann B, Gikalov I, Schiemann O, Fenner H (1985) Untersuchungen zur klinischen Pharmakokinetik von Allopurinol Arzneimittelforsch/Drug-Res 35 [I]: 760–765
Brockmeier D, Grigoleit H-G, Leonhardt H (1985) Absorption of glibenclamide from different sites of the gastro-intestinal tract. Eur J Clin Pharmacol 29: 193–197
Klaus E, Alpermann HG, Caspritz W, Linz W, Schölkens B (1983) Vascular effects of piretanide. Arzneimittelforsch/Drug-Res 33 [II]: 1273–1276
Merkel W, Bormann D, Mania D, Muschaweck R, Hropot M (1976) Piretanide (HOE 118) a new high ceiling salidiuretic. Eur J Med Chem 11: 399–406
Heptner W, Baudner S, Dagrosa EE, Hellstern C, Irmisch R, Strecker H, Wissmann H (1984) A radioimmunoassay to measure piretanide in human serum and urine. J Immunoassay 5: 13–27
Dost FH (1958) Über ein einfaches statistisches Dosis-Umsatz-Gesetz. Klin Wochenschr 34: 655–657
von Hattingberg HM, Brockmeier D (1982) A concept for the assessment of bioavailability in complex systems in terms of amounts and rates. In: Bozler G, van Rossum JM (eds) Titisee Conference Pharmacokinetics during Drug Development: Data analysis and evaluation techniques. Oct. 1978. Gustav Fischer, Stuttgart, pp 315–323
von Hattingberg HM, Brockmeier D, Voegele D (1980) A method for in vivo — in vitro correlation using the additivity of mean times in biopharmaceutical models. In: Rietbrock N, Woodcock BG, Neuhaus G (eds) Methods in clinical pharmacology. Vieweg, Braunschweig Wiesbaden, pp 85–93
Brockmeier D (1984) In vitro — in vivo correlation, a time scaling problem? Evaluation of mean times. Arzneimittelforsch/Drug-Res 34 [II]: 1604–1607
Lienert GA (1973) Verteilungsfreie Methoden in der Biostatistik. Verlag Anton Hain, Meisenheim am Glan, pp 413–428
Heller R (1981) Ein FORTRAN-Programm zur Berechnung exakter P-Werte für Fisher-Pitman-Randomisierungstest. EDV Med Biol 12 [2]: 62–64
Brodie BB, Hogben CAM (1957) Some physico-chemical factors in drug action. J Pharm Pharmacol 9: 345–380
Shore PA, Brodie BB, Hogben CAM (1957) The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther 119: 361–369
Kruis W, Büll U, Eisenburg J, Paumgartner G (1982) Retrograde colonic spread of sulphasalazine enemas. Scand J Gastroenterol 17: 933–938
Wilson CG, Parr GD, Kennerley JW, Taylor MJ, Davis SS, Hardy JG, Rees JA (1984) Pharmacokinetics and in vivo scintigraphic monitoring of a sustained release acetylsalicylic acid formulation. Int J Pharm 18: 1–8
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brockmeier, D., Grigoleit, H.G. & Leonhardt, H. The absorption of piretanide from the gastro-intestinal tract is site-dependent. Eur J Clin Pharmacol 30, 79–82 (1986). https://doi.org/10.1007/BF00614200
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00614200